期刊文献+

MEK5基因siRNA重组腺病毒表达载体的构建及其对MEK5的表达抑制 被引量:1

Construction of MEK5 siRNA Recombinant Adenovirus Vector and Its Inhibitory Effect on MEK5 Expression
原文传递
导出
摘要 目的 构建人MEK5基因的小干扰RNA(siRNA)重组腺病毒表达载体,观察其在胃腺癌SGC7901细胞中对MEK5的表达抑制.方法 设计并合成针对人MEK5基因3个不同部位siRNA靶点的模板DNA序列,以MluⅠ及XhoⅠ克隆入pRNAT-H1.1/Adeno穿梭载体中,将得到的重组穿梭质粒用PmeⅠ线性化后在大肠埃希菌BJ5183中与腺病毒骨架质粒pAdEasy-1进行同源重组.将PacⅠ酶切鉴定正确的重组腺病毒质粒经乙醇沉淀后转染293A细胞,包装得到具有感染能力的pAd-MEK5-siRNA重组腺病毒.病毒体外转导人胃腺癌SGC7901细胞,Western印迹法检测其对MEK5表达的抑制.结果 经酶切和测序鉴定均证实pAd-MEK5-siRNA重组腺病毒载体构建成功,其插入序列正确无误.Western印迹检测结果显示pAd-MEK5-siRNA2可抑制MEK5基因的表达,其有效抑制率达75.5 %.结论本研究成功地构建了针对人MEK5基因的siRNA重组腺病毒载体,为进一步深入研究MEK5基因在人胃腺癌细胞中的作用和功能奠定了基础. Objective To construct a small interfering RNA (siRNA) adenovirus expression vector targeting MEK5 and to study its inhibitive effect on MEK5 expression in gastric adenocarcinomas SGC7901 ceils. Methods Three different siRNA template DNA sequences of MEK5 gene were designed by Genscript siRNA design software. The corresponding DNA vitro, annealed and then cloned into the pRNAT-H1.1/Adeno shuttle fragments were synthesized in vector. The recombinant shuttle vectors were confirmed by DNA sequencing, then transformed into Escherichia coli B J5183 carry- ing backbone plasmid PAdeasy-1 to obtain adenovirus plasmid through homologous recombina- tion. The adenovirus plasmid was transfected into 293A cells to form adenovirus particle. Then, the adenovirus particles were transduced into SGC7901 cells. Western blot was carried out to analyze the suppression effect of MEK5 siRNA vectors in SGC7901 cells and to screen the best vector that had the highest effect on inhibition of MEK5 expression. Results DNA sequencing and western blot confirmed the effective silence effect on MEK5 by one MEK5 siRNA adenovirus expression vector pRNATH1.1/Adeno-MEK5 siRNA2, with a suppression ratio up to 75.5 %. Conclusion The recombinant pAd-MEKS-siRNA expression vector effectively targeting MEK5 provides a tool for further investigation of MEK5 function in gastric adenocarcinomas cells.
出处 《医学分子生物学杂志》 CAS CSCD 2011年第6期506-511,共6页 Journal of Medical Molecular Biology
基金 福建省自然科学基金(No.2009J01181),南京军区医药卫生科研基金(No.08MA100)
关键词 腺病毒载体 基因表达与调控 MEK5基因 adenovirus vector gene expression and regulation MEK5 gene
  • 相关文献

参考文献11

  • 1MEHTA P B,JENKINS B L,MCCARTHY L,et al.MEK5 overexpression is associated with metastatic prostate cancer,and stimulates proliferation,MMP-9 expression and invasion[J].Oncogene,2003,22:1381-1389.
  • 2SONG H,JIN X,LIN J.Stat3 upregulates MEK5 expression in human breast cancer cells[J].Oncogene,2004,23:8301-8309.
  • 3沈瑞明,兰风华,钱凤英,董荔红,黄俏佳.siRNA表达载体稳定沉默肺癌A549细胞MEKK3基因的细胞株建立[J].医学分子生物学杂志,2010,7(4):316-322. 被引量:1
  • 4钱凤英,黄俏佳.Transgelin基因真核表达载体的构建及其对胃腺癌AGS细胞增殖的影响[J].医学分子生物学杂志,2010,7(6):517-522. 被引量:4
  • 5钱凤英,兰风华,董荔红,黄俏佳.MEKK3基因siRNA重组腺病毒表达载体的构建及其对胃腺癌AGS细胞MEKK3的表达抑制[J].医学分子生物学杂志,2011,8(4):334-339. 被引量:2
  • 6OHGAKI H,MATSUKURA N.Stomach cancer[M].In:Stewart B W,Kleihues P,eds.World Cancer Report.Lyon:IARC Press,2003,197-201.
  • 7LU Z,COX-HIPKIN M A,WINDSOR W T,et al.3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway[J].Mol Cancer Res,2010,8(3):421-432.
  • 8PLOTNIKOV A,ZEHORAI E,PROCACCIA S,al.The MAPK cascades:Signaling components,nuclear roles and mechanisms of nuclear translocation[J].Biochim Biophys Acta,2011,1813(9):1619-1633.
  • 9WHYTE J,BERGIN O,BIANCHI A,et al.Key signalling nodes in mammary gland development and cancer.Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development[J].Breast Cancer Res,2009,11(5):209-223.
  • 10SINGH R K,LOKESHWAR B L.The IL-8-Regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth[J].Cancer Res,2011,71(9):3268-3277.

二级参考文献36

  • 1Gao N,Flynn D C,Zhang Z,et al. The G1 cell cycle progression and the expression of G1 cyclins are regulated by PDK/ AKT/mTOR/p70S6KI signaling in human ovarian cancer cells[J]. Am J Physiol Cell Physiol, 2004,287(127) : 281- 291.
  • 2Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics 2002[J]. CA Cancer J Clin,2005,55(957) :74-108.
  • 3Sultana A,Smith C T,Cunningham D,et al. Meta- analyses of chemotherapy for locally advanced and metastatic pancreatic cancer[J]. J Clin Oncol,2007,25(18) :2607 -2615.
  • 4Giroux V, Malicet C, Barthet M. p8 is a new target of gemcitabine in pancreatic cancer cells[J]. Clin Cancer Res, 2006,12 (1) :235- 241.
  • 5Nicholson K M,Anderson N G. The protein kinase B/Akt signalling pathway in human malignancy[J]. Cell Signal, 2002, 14(5):381 -395.
  • 6Azorsa D O, Gonzales I M, Basu G D, et al. Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer[J]. J Transt Med,2009,11 (7) 43.
  • 7ASSINDER S J, STANTON J A, PRASAD P D. Transgelin: an ac- tin-binding protein and tunmur suppressor[ J ]. Int J Bioehem Cell Biol,2009,41 ( 3 ) :482-486.
  • 8YANG Z, CHANG Y J, MIYAMOTO H, et al. Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen recep- tor transactivation and prostate cancer cell growth [ J ]. Mol Endo- erinol,2007,21 (2) :343-358.
  • 9M I KURIYA K, KURAMITSU Y, R YOZAWA S, et al. Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by lwo-dinlensional electrophore- sis and liquid chromatography-mass spectrometry/mass spectrome- try[ J]. Int J Oncol,2007,30(4) :849-855.
  • 10SHI Y Y,WANG H C,YIN Y H,et al. Identification and analysis of tumour-associated antigens in hepatocellular carcinoma[ J]. Br J Cancer, 2005, ( 92 ) : 929-934.

共引文献6

同被引文献13

  • 1WOODARD J,SASSANO A,HAY N. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 Up-regulation in renal cell carcinoma[J].{H}Clinical Cancer Research,2008,(14):4640-4649.
  • 2ZHANG H,CHEN D,RINGLER J. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo[J].{H}CANCER RESEARCH,2010,(10):3996-4004.
  • 3ARBOLEDA M J,LYONS J F,KABBINAVAR F F. Overexpression of AKT2/protein kinasebβ leads to up-regulation of β1 integrins,increased invasion,and metastasis of human breast and ovarian cancer cells[J].{H}CANCER RESEARCH,2003,(01):196-206.
  • 4VANDERMOERE F,EI YAZIDI-BELKOURA I,DEMONT Y. Proteomics exploration reveals that actin is a signaling target of the kinase Akt[J].{H}Molecular & Cellular Proteomics,2006,(01):114-124.
  • 5ALTOMARE D A,WANG H Q,SKELE K L. AKT and mTOR ph-osphorylation is frequently detected in ovarian cancer and can be targ-eted to disrupt ovarian tumor cell growth[J].{H}ONCOGENE,2004.5853-5857.
  • 6SUNG J S,PARK K H,KIM S T. Discovery and evaluation of polymorphisms in the AKT2 and AKT3 promoter regions for risk of korean lung cancer[J].Genomics Inform,2012,(03):167-174.
  • 7JEMAL A,SIEGEL R,WARD E. Cancer statistics,2008[J].{H}CA-A Cancer Journal for Clinicians,2008.71-96.
  • 8MERENBAKH-LAMIN K,BEN-BARUCH N,YEHESKEL A. D538G Mutation in estrogen receptor-α:a novel mechanism for acquired endocrine resistance in breast cancer[J].{H}CANCER RESEARCH,2013,(23):6856-6864.
  • 9CHEUNG M,SHARMA A,SUBBARAO V. Akt3 and mutant V600EB-Raf cooperate to promote early melanoma development[J].{H}CANCER RESEARCH,2008.68.
  • 10SHARMA A,SHARMA A K,MADHUNAPANTULA S V. Targeting Akt3 signaling in malignant melanoma using isoselenocyanates[J].{H}Clinical Cancer Research,2009,(05):1674-1684.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部